Candriam S.C.A. Johnson & Johnson Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Johnson & Johnson stock. As of the latest transaction made, Candriam S.C.A. holds 265,152 shares of JNJ stock, worth $40.6 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

265,152

Previous 280,235 5.38%

Holding current value

$40.6 Million

Previous $41 Million 4.91%

% of portfolio

0.25%

Previous 0.25%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$145.48 - $167.38 $2.19 Million - $2.52 Million	-15,083 Reduced 5.38%	265,152 $43 Million
Q2 2024 Aug 05, 2024	BUY	$144.38 - $157.78 $972,543 - $1.06 Million	6,736 Added 2.46%	280,235 $41 Million
Q1 2024 May 03, 2024	SELL	$155.22 - $162.74 $5.24 Million - $5.49 Million	-33,731 Reduced 10.98%	273,499 $43.3 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $26.2 Million - $28.5 Million	-179,678 Reduced 36.9%	307,230 $48.2 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $51.8 Million - $58.1 Million	-332,735 Reduced 40.6%	486,908 $75.8 Million
Q2 2023 Aug 08, 2023	SELL	$154.35 - $166.11 $6.77 Million - $7.29 Million	-43,858 Reduced 5.08%	819,643 $136 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $26 Million - $31.1 Million	172,445 Added 24.95%	863,501 $134 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $31.3 Million - $35.1 Million	195,274 Added 39.39%	691,056 $122 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $23.6 Million - $26.2 Million	-145,989 Reduced 22.75%	495,782 $81 Million
Q2 2022 Aug 03, 2022	SELL	$168.19 - $186.01 $38.7 Million - $42.8 Million	-229,897 Reduced 26.37%	641,771 $114 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $575,313 - $653,348	-3,638 Reduced 0.42%	871,668 $154 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $16.7 Million - $18.5 Million	-107,120 Reduced 10.9%	875,306 $150 Million
Q3 2021 Nov 09, 2021	BUY	$161.5 - $179.47 $54.5 Million - $60.5 Million	337,232 Added 52.27%	982,426 $159 Million
Q2 2021 Jul 20, 2021	BUY	$159.48 - $171.07 $6.58 Million - $7.06 Million	41,249 Added 6.83%	645,194 $106 Million
Q1 2021 Apr 29, 2021	SELL	$153.07 - $170.48 $1,071 - $1,193	-7 Reduced -0.0%	603,945 $91.3 Million
Q4 2020 Jan 22, 2021	BUY	$137.11 - $157.38 $25.7 Million - $29.6 Million	187,791 Added 45.12%	603,952 $95 Million
Q3 2020 Oct 19, 2020	BUY	$140.38 - $153.83 $811,396 - $889,137	5,780 Added 1.41%	416,161 $62 Million
Q2 2020 Jul 23, 2020	BUY	$128.81 - $155.51 $1.9 Million - $2.29 Million	14,735 Added 3.72%	410,381 $57.7 Million
Q1 2020 May 26, 2020	BUY	$111.14 - $153.99 $4,445 - $6,159	40 Added 0.01%	395,646 $56.4 Million
Q4 2019 Jan 21, 2020	SELL	$127.5 - $146.44 $2.66 Million - $3.06 Million	-20,887 Reduced 5.01%	395,606 $58,000
Q3 2019 Feb 05, 2020	SELL	$126.95 - $142.14 $4,189 - $4,690	-33 Reduced 0.01%	416,493 $53.9 Million
Q3 2019 Oct 21, 2019	BUY	$126.95 - $142.14 $507,038 - $567,707	3,994 Added 0.97%	416,526 $58,000
Q2 2019 Aug 01, 2019	BUY	$131.15 - $144.24 $1.82 Million - $2.01 Million	13,912 Added 3.49%	412,532 $62.2 Million
Q1 2019 May 02, 2019	BUY	$125.72 - $139.79 $2.65 Million - $2.95 Million	21,096 Added 5.59%	398,620 $61 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $5.8 Million - $6.98 Million	-47,205 Reduced 11.11%	377,524 $48.7 Million
Q3 2018 Nov 07, 2018	BUY	$121.58 - $142.88 $28,692 - $33,719	236 Added 0.06%	424,729 $58.7 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $623,626 - $688,182	5,223 Added 1.25%	424,493 $51.5 Million
Q1 2018 May 09, 2018	BUY	$125.1 - $148.14 $10.6 Million - $12.5 Million	84,393 Added 25.2%	419,270 $53.7 Million
Q4 2017 Feb 07, 2018	SELL	$131.22 - $143.62 $26.2 Million - $28.7 Million	-199,812 Reduced 37.37%	334,877 $46.8 Million
Q3 2017 Nov 03, 2017	BUY	$129.47 - $135.38 $69.2 Million - $72.4 Million	534,689	534,689 $69.5 Million

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account